Stock News

Spears Abacus Advisors Upped General Electric Co (GE) Position by $645,759; As Acadia Pharmaceuticals (ACAD) Market Value Declined, Knott David M Has Cut by $648,000 Its Position

Knott David M decreased its stake in Acadia Pharmaceuticals Inc. (ACAD) by 43.68% based on its latest 2017Q2 regulatory filing with the SEC. Knott David M sold 24,000 shares as the company’s stock declined 29.10% while stock markets rallied. The institutional investor held 30,947 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $863,000, down from 54,947 at the end of the previous reported quarter. Knott David M who had been investing in Acadia Pharmaceuticals Inc. for a number of months, seems to be less bullish one the $3.60B market cap company. The stock increased 0.03% or $0.01 during the last trading session, reaching $28.98. About 1.07M shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has declined 15.19% since December 15, 2016 and is downtrending. It has underperformed by 31.89% the S&P500.

Spears Abacus Advisors Llc increased its stake in General Electric Co (GE) by 1.95% based on its latest 2017Q2 regulatory filing with the SEC. Spears Abacus Advisors Llc bought 23,917 shares as the company’s stock declined 7.64% while stock markets rallied. The institutional investor held 1.25M shares of the consumer electronics and appliances company at the end of 2017Q2, valued at $33.85M, up from 1.23M at the end of the previous reported quarter. Spears Abacus Advisors Llc who had been investing in General Electric Co for a number of months, seems to be bullish on the $154.54 billion market cap company. The stock increased 1.02% or $0.18 during the last trading session, reaching $17.82. About 87.99M shares traded or 17.71% up from the average. General Electric Company (NYSE:GE) has declined 4.46% since December 15, 2016 and is downtrending. It has underperformed by 21.16% the S&P500.

Spears Abacus Advisors Llc, which manages about $1.25B and $804.72M US Long portfolio, decreased its stake in Danaher Corp Del (NYSE:DHR) by 16,870 shares to 332,521 shares, valued at $28.06M in 2017Q2, according to the filing. It also reduced its holding in Celgene Corp (NASDAQ:CELG) by 9,981 shares in the quarter, leaving it with 196,449 shares, and cut its stake in Apple Inc (NASDAQ:AAPL).

Investors sentiment decreased to 0.79 in 2017 Q2. Its down 0.03, from 0.82 in 2017Q1. It worsened, as 85 investors sold GE shares while 816 reduced holdings. 111 funds opened positions while 598 raised stakes. 4.61 billion shares or 0.66% more from 4.58 billion shares in 2017Q1 were reported. Of Virginia Va accumulated 442,136 shares. Spc Fincl has invested 0.3% of its portfolio in General Electric Company (NYSE:GE). Moreover, Banced Corp has 1.9% invested in General Electric Company (NYSE:GE) for 37,975 shares. Moreover, Wellington Management Llp has 0.33% invested in General Electric Company (NYSE:GE). Mitchell Mcleod Pugh Williams owns 47,456 shares. Vaughan David Invests Il has invested 1.17% in General Electric Company (NYSE:GE). 20,585 are owned by Seizert Capital Prtn Limited Liability Corp. Hamel Assoc, New Jersey-based fund reported 203,522 shares. Gsa Cap Prtn Ltd Liability Partnership reported 0.18% of its portfolio in General Electric Company (NYSE:GE). Fiduciary Services Of The Southwest Tx owns 2.65% invested in General Electric Company (NYSE:GE) for 318,144 shares. Phillips Financial Limited reported 10,589 shares. Pittenger & Anderson Incorporated has invested 0.01% of its portfolio in General Electric Company (NYSE:GE). Mayo Invest Advisers Limited Co has invested 2.12% of its portfolio in General Electric Company (NYSE:GE). Boston Family Office Ltd accumulated 394,815 shares. New York State Teachers Retirement invested 1.03% in General Electric Company (NYSE:GE).

Among 25 analysts covering General Electric Company (NYSE:GE), 10 have Buy rating, 5 Sell and 10 Hold. Therefore 40% are positive. General Electric Company had 79 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Hold” rating by Deutsche Bank on Tuesday, August 25. The firm earned “Underweight” rating on Wednesday, November 1 by JP Morgan. Cowen & Co maintained the shares of GE in report on Monday, August 7 with “Hold” rating. The stock of General Electric Company (NYSE:GE) has “Outperform” rating given on Monday, November 30 by RBC Capital Markets. Barclays Capital maintained it with “Overweight” rating and $30 target in Monday, October 5 report. The rating was maintained by Citigroup with “Buy” on Monday, October 23. The stock of General Electric Company (NYSE:GE) earned “Buy” rating by S&P Research on Monday, August 17. The company was initiated on Thursday, January 21 by Citigroup. The rating was upgraded by Credit Suisse to “Focus List” on Wednesday, September 16. Morgan Stanley maintained General Electric Company (NYSE:GE) on Thursday, October 6 with “Equal-Weight” rating.

Since August 8, 2017, it had 2 insider purchases, and 1 insider sale for $4.48 million activity. 103,983 shares valued at $2.66 million were bought by Flannery John Leonard on Tuesday, August 8. TISCH JAMES S bought $2.46 million worth of stock or 100,000 shares.

Knott David M, which manages about $239.58 million US Long portfolio, upped its stake in Ryman Hospitality Ppty Inc. (NYSE:RHP) by 12,000 shares to 12,400 shares, valued at $794,000 in 2017Q2, according to the filing. It also increased its holding in General Electric (NYSE:GE) by 24,000 shares in the quarter, for a total of 28,680 shares, and has risen its stake in Du Pont E I De Nemours & Co. (NYSE:DD).

Analysts await ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to report earnings on February, 27. They expect $-0.59 EPS, up 9.23% or $0.06 from last year’s $-0.65 per share. After $-0.53 actual EPS reported by ACADIA Pharmaceuticals Inc. for the previous quarter, Wall Street now forecasts 11.32% negative EPS growth.

Investors sentiment decreased to 1.05 in 2017 Q2. Its down 0.06, from 1.11 in 2017Q1. It dived, as 31 investors sold ACAD shares while 54 reduced holdings. 21 funds opened positions while 68 raised stakes. 115.85 million shares or 0.73% less from 116.70 million shares in 2017Q1 were reported. Manufacturers Life Ins Co The has 4,380 shares for 0% of their portfolio. Moreover, Great West Life Assurance Can has 0% invested in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 11,789 shares. Tocqueville Asset Mgmt Lp stated it has 0.03% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). 250,000 are owned by Acuta Capital Prtn Ltd Liability. Franklin invested in 3.57 million shares or 0.05% of the stock. Reilly Advsr Limited Liability Company holds 425 shares. Mark Sheptoff Financial Planning has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Bnp Paribas Arbitrage Sa has invested 0% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). State Street reported 3.75 million shares. Price T Rowe Associates Inc Md holds 0.02% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) for 3.46 million shares. Wells Fargo Mn owns 175,368 shares for 0% of their portfolio. Prudential Fincl has invested 0.01% in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Profund Advsrs Limited Liability Co accumulated 36,274 shares. Walleye Trading Limited Liability Com has invested 0% of its portfolio in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). Fiera, a Quebec – Canada-based fund reported 134,501 shares.

Since August 9, 2017, it had 0 insider purchases, and 3 insider sales for $2.96 million activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *